By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Latest Headlines
  • >
  • NHS to roll out new gene therapy for metachromatic leukodystrophy – Health Europa

NHS to roll out new gene therapy for metachromatic leukodystrophy – Health Europa

Monday, 7 February, 2022

NHS to roll out new gene therapy for metachromatic leukodystrophy – Health Europa

© iStock/Jacek_Sopotnicki

 
The NHS has agreed on a deal for life-saving treatment for metachromatic leukodystrophy that will offer babies and young children the prospect of a normal life.
The revolutionary gene therapy treatment named Libmeldy is used to treat metachromatic leukodystrophy is reportedly the most expensive drug in the world. Metachromatic leukodystrophy causes severe damage to the child’s nervous system and organs, resulting in a life expectancy of between five and eight years.
This deal is part of the NHS Long Term Plan, a plan drawn up by frontline staff, patient groups, and national experts to create a service fit for the future. The aim is to provide cutting-edge treatments and therapies to patients.
Read more at: https://www.healtheuropa.eu/nhs-to-roll-out-new-gene-therapy-for-metachromatic-leukodystrophy/113299/

Categories :
  • Latest Headlines
  • Leukodystrophies
Socials :

Recent posts

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Copyright © 2022 All rights reserved